Arcadia Biosciences Inc Dossier - Source-backed chat

Arcadia Biosciences Inc

RKDANASDAQ

SectorConsumer Staples

IndustryAgricultural Products and Services

Beta (adjusted)0.70

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $0.28Price as of 30 Sep 2026

Data confidence Sign in to view data confidence

Market Cap $674.6K

Enterprise Value −$3.5M

Shares Outstanding 2.5M diluted

Next Earnings Date12 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Arcadia Biosciences (RKDA) is facing severe liquidity constraints and substantial doubt regarding its ability to continue as a going concern. Despite positive underlying volume growth in its core Zola coconut water brand (+18% YoY in Q1 2026) and aggressive cost-cutting that brought SG&A to historic lows, the company remains highly unprofitable. The termination of its proposed business combination with Roosevelt Resources in late 2025 has forced Arcadia to rely on highly dilutive private placements and warrant exercises to survive. With a persistent net loss ($4.4 million in Q1 2026) and a business model that continues to burn cash, the stock presents an asymmetric downside risk for long-term investors.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

The company fails to secure additional funding or execute a strategic transaction. The Fall 2026 product launch fails to gain traction, and cash reserves are depleted rapidly. The company is forced to undergo a severe restructuring, liquidate assets at distressed valuations, or face delisting from the Nasdaq Capital Market due to non-compliance with minimum bid price or equity requirements.

Base CaseCentral scenario

The company continues to grow its Zola coconut water brand and successfully launches its new product in Fall 2026. However, cash burn remains high, and the $4 million raised in the June 2026 private placement only extends the runway by a few quarters. Ongoing dilution from preferred investment options and warrant exercises caps any potential equity upside, keeping the stock under severe pressure.

Bull CaseUpside scenario

Successful expansion of the high-margin Zola coconut water brand, combined with a successful merger or strategic transaction leveraging its Nasdaq listing and remaining assets, driving significant shareholder value.

Scenarios reflect our research view at the research date.

Key Investment Merits

Strong underlying brand momentum for Zola coconut water, with unit volumes increasing 18% YoY in Q1 2026.
Successful execution of cost-reduction initiatives, driving SG&A expenses to their lowest level in the company's history as a public entity.
Active evaluation of strategic alternatives to maximize shareholder value.

Key Investment Risks

Substantial doubt about the company's ability to continue as a going concern due to insufficient cash runway.
High risk of ongoing equity dilution from private placements, warrant inducements, and preferred investment options.
History of persistent net losses and negative cash flows from operating activities.

Thesis Invalidation Triggers

Execution of a highly accretive merger, acquisition, or asset sale that fully funds operations without further equity dilution.
Achieving operational cash flow break-even ahead of schedule driven by explosive growth in Zola and the new product line.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.